首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting.
【24h】

Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting.

机译:X链接的超IgM综合征的体细胞超突变分析表明突变靶向中的特定缺陷。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Subjects with X-linked hyper-IgM syndrome (X-HIgM) have a markedly reduced frequency of CD27(+) memory B cells, and their Ig genes have a low level of somatic hypermutation (SHM). To analyze the nature of SHM in X-HIgM, we sequenced 209 nonproductive and 926 productive Ig heavy chain genes. In nonproductive rearrangements that were not subjected to selection, as well as productive rearrangements, most of the mutations were within targeted RGYW, WRCY, WA, or TW motifs (R = purine, Y = pyrimidine, and W = A or T). However, there was significantly decreased targeting of the hypermutable G in RGYW motifs. Moreover, the ratio of transitions to transversions was markedly increased compared with normal. Microarray analysis documented that specific genes involved in SHM, including activation-induced cytidine deaminase (AICDA) and uracil-DNA glycosylase (UNG2), were up-regulated in normal germinal center (GC) B cells, but not induced by CD40 ligation. Similar results were obtained from light chain rearrangements. These results indicate that in the absence of CD40-CD154 interactions, there is a marked reduction in SHM and, specifically, mutations of AICDA-targeted G residues in RGYW motifs along with a decrease in transversions normally related to UNG2 activity.
机译:X链接的超IgM综合征(X-HIgM)的受试者具有显着降低的CD27(+)记忆B细胞的频率,其Ig基因的体细胞超突变(SHM)水平较低。为了分析X-HIgM中SHM的性质,我们对209个非生产性和926个生产性Ig重链基因进行了测序。在未进行选择的非生产性重排以及生产性重排中,大多数突变都位于靶向的RGYW,WRCY,WA或TW基序内(R =嘌呤,Y =嘧啶,W = A或T)。但是,RGYW主题中的高变G的靶向明显降低。此外,与正常相比,过渡与颠换的比例显着增加。微阵列分析表明,SHM中涉及的特定基因,包括激活诱导的胞苷脱氨酶(AICDA)和尿嘧啶DNA糖基化酶(UNG2),在正常生发中心(GC)B细胞中被上调,但并未被CD40连接诱导。从轻链重排获得类似的结果。这些结果表明,在不存在CD40-CD154相互作用的情况下,SHM显着降低,尤其是RGYW基序中以AICDA为靶点的G残基突变,以及通常与UNG2活性相关的转化降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号